|
|
|
|
| LEADER |
00000cam a2200000 a 4500 |
| 001 |
SCIDIR_ocn947083512 |
| 003 |
OCoLC |
| 005 |
20231120112104.0 |
| 006 |
m o d |
| 007 |
cr |n||||||||| |
| 008 |
160422s2016 enk o 001 0 eng d |
| 040 |
|
|
|a IDEBK
|b eng
|e pn
|c IDEBK
|d N$T
|d YDXCP
|d OPELS
|d N$T
|d OCLCF
|d EBLCP
|d CDX
|d OCLCQ
|d U3W
|d UUM
|d D6H
|d OCLCQ
|d WYU
|d AU@
|d OCLCQ
|d S2H
|d OCLCO
|d VT2
|d OCLCO
|d OCLCQ
|d OCLCO
|
| 019 |
|
|
|a 950463741
|a 958095976
|a 1066438080
|a 1235824809
|
| 020 |
|
|
|a 0128030739
|q (electronic bk.)
|
| 020 |
|
|
|a 9780128030738
|q (electronic bk.)
|
| 020 |
|
|
|z 9780128030721
|
| 020 |
|
|
|z 0128030720
|
| 035 |
|
|
|a (OCoLC)947083512
|z (OCoLC)950463741
|z (OCoLC)958095976
|z (OCoLC)1066438080
|z (OCoLC)1235824809
|
| 050 |
|
4 |
|a RA1231.M52
|
| 072 |
|
7 |
|a MED
|x 071000
|2 bisacsh
|
| 082 |
0 |
4 |
|a 615.9/08
|2 23
|
| 100 |
1 |
|
|a Aaseth, Jan.
|
| 245 |
1 |
0 |
|a Chelation therapy in the treatment of metal intoxication /
|c Jan Aaseth, Guido Criponi, Ole Andersen.
|
| 260 |
|
|
|a London :
|b Academic Press,
|c 2016.
|
| 300 |
|
|
|a 1 online resource
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 500 |
|
|
|a Includes index.
|
| 588 |
0 |
|
|a Print version record.
|
| 505 |
0 |
|
|a Cover; Title Page; Copyright Page; Contents; Contributors; Preface; List of Abbreviations; Chapter 1 -- General Chemistry of Metal Toxicity and Basis for Metal Complexation; 1.1 -- General chemistry of metals; 1.2 -- Essential and nonessential elements; 1.3 -- Effects of toxic exposure of an essential or nonessential metal; 1.3.1 -- Basic Concepts in Chemical Toxicity Testing; 1.3.2 -- Exposure Patterns and Mechanisms of Metal Toxicity; 1.3.3 -- Gastrointestinal Effects of Metal Exposure; 1.3.4 -- Respiratory Effects of Metal Exposure; 1.3.5 -- Hepatic and Renal Effects.
|
| 505 |
8 |
|
|a 1.3.6 -- Effects on the Nervous System1.3.7 -- Hematological Effects; 1.3.8 -- Cardiovascular Effects; 1.3.9 -- Metal Allergies; 1.3.10 -- Carcinogenic Effects; 1.4 -- Basis for metal complex formation with endogenous and exogenous ligands; 1.5 -- Endogenous complexing and detoxification compounds; 1.5.1 -- Albumin; 1.5.2 -- Transferrin and Ferritin; 1.5.3 -- Glutathione; 1.5.4 -- Metallothionein; 1.5.5 -- Selenoproteins; 1.6 -- Conclusions; References; Chapter 2 -- Chelating Agents as Therapeutic Compounds-Basic Principles; 2.1 -- Chemical and biological principles for in vivo chelation; 2.1.1 -- Stability.
|
| 505 |
8 |
|
|a 2.1.2 -- Selectivity2.1.3 -- Kinetic Aspects of Chelation; 2.1.4 -- Absorption and Bioavailability of Chelating Agents; 2.2 -- Chelating agents: chemistry, kinetics, and toxicology; 2.2.1 -- BAL, DMPS, DMSA; 2.2.2 -- D-penicillamine; 2.2.3 -- Triethylenetetramine; 2.2.4 -- Deferoxamine, Deferiprone, and Deferasirox; 2.2.5 -- EDTA and DTPA; 2.2.6 -- Prussian Blue; References; Chapter 3 -- Diagnosis and Evaluation of Metal Poisonings and Chelation Therapy; 3.1 -- Introduction; 3.2 -- History of symptoms and exposure; 3.3 -- Clinical findings; 3.4 -- Genetic disorders with systemic metal accumulation.
|
| 505 |
8 |
|
|a 3.5 -- Toxicological analyses3.6 -- Biochemical measurements; 3.7 -- Physiological, radiological, and ultrasonographic investigations; References; Chapter 4 -- Chelation Treatment During Acute and Chronic Metal Overexposures-Experimental and Clinical Studies; 4.1 -- Introduction; 4.2 -- Aluminum; 4.2.1 -- Selected Representative Animal Studies; 4.2.2 -- Selected Representative Clinical Studies; 4.2.3 -- Conclusions; 4.3 -- Antimony; 4.3.1 -- Animal Experiments; 4.3.2 -- Clinical Cases; 4.3.3 -- Conclusion; 4.4 -- Arsenic; 4.4.1 -- Selected Animal Experiments; 4.4.2 -- Clinical Studies.
|
| 505 |
8 |
|
|a 4.4.3 -- Discussion and Conclusion4.5 -- Beryllium; 4.5.1 -- Experimental Chelation Studies; 4.5.2 -- Clinical Experience; 4.5.3 -- Conclusion; 4.6 -- Bismuth; 4.6.1 -- Animal Chelation Studies; 4.6.2 -- Clinical Chelation Studies; 4.6.3 -- Conclusion; 4.7 -- Cadmium; 4.7.1 -- Animal Chelation Experiments; 4.7.2 -- Clinical Chelation Studies; 4.7.3 -- Conclusion; 4.8 -- Chromium; 4.8.1 -- Animal Experimental Studies; 4.8.2 -- Clinical Cases; 4.8.3 -- Conclusion; 4.9 -- Cobalt; 4.9.1 -- Chelation, Animal Experiments; 4.9.2 -- Chelation, Clinical Studies; 4.9.3 -- Conclusion; 4.10 -- Copper.
|
| 505 |
8 |
|
|a 4.10.1 -- Animal Chelation Studies.
|
| 650 |
|
0 |
|a Chelation therapy.
|
| 650 |
|
2 |
|a Chelation Therapy
|0 (DNLM)D015913
|
| 650 |
|
6 |
|a Ch�elation (Th�erapeutique)
|0 (CaQQLa)201-0033638
|
| 650 |
|
7 |
|a MEDICAL
|x Pharmacology.
|2 bisacsh
|
| 650 |
|
7 |
|a Chelation therapy
|2 fast
|0 (OCoLC)fst00852798
|
| 700 |
1 |
|
|a Criponi, Guido.
|
| 700 |
1 |
|
|a Andersen, Ole.
|
| 776 |
0 |
8 |
|i Print version:
|a Aaseth, Jan.
|t Chelation Therapy in the Treatment of Metal Intoxication.
|d : Elsevier Science, �2016
|z 9780128030721
|
| 856 |
4 |
0 |
|u https://sciencedirect.uam.elogim.com/science/book/9780128030721
|z Texto completo
|
